Page last updated: 2024-10-28

hydroxychloroquine and Premature Birth

hydroxychloroquine has been researched along with Premature Birth in 33 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"Hydroxychloroquine (HCQ) is the primary medication in the treatment of pregnancy with systemic lupus erythematosus (SLE) for its efficacy and safety."9.12Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis. ( Liu, Y; Wei, Y; Yang, H; Zhang, Y, 2021)
"Hydroxychloroquine (HCQ) is often needed to manage disease activity in systemic lupus erythematosus (SLE) during pregnancy."9.12Hydroxychloroquine in lupus pregnancy. ( Clowse, ME; Magder, L; Petri, M; Witter, F, 2006)
"The objective of this meta-analysis was to determine whether gestational use of hydroxychloroquine (HCQ) for autoimmune disorders leads to an increase in the risk for adverse pregnancy outcomes."8.93Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. ( Kaplan, YC; Koren, G; Nickel, C; Ozsarfati, J, 2016)
"Among pregnancies exposed to 4-aminoquinolines (chloroquine and HCQ), no increased risk of major birth defects, preterm birth, or SGA was identified."8.02Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. ( Andersen, JT; Andersson, NW; Skov, L, 2021)
" Multiple logistic analysis adjusting for body mass index (BMI), lupus nephritis, serum uric acid, and estimated glomerular filtration rate revealed HCQ treatment was associated with exceedingly lower risk of preeclampsia in SLE pregnancy (odds ratio (OR) 0."7.91Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. ( Cha, HS; Chae, J; Choi, SJ; Kim, YM; Oh, S; Roh, CR; Seo, MR, 2019)
" Lupus flares were predicted by HCQ discontinuation, a history of lupus nephritis, high pre-pregnancy serum uric acid and low C4 levels."7.81Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. ( Ju, JH; Ko, HS; Koh, JH; Kwok, SK; Park, SH, 2015)
"A total of 40 infants born from mothers affected by rheumatic diseases and treated with hydroxychloroquine during pregnancy were enrolled in a prospective observational study."7.73Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. ( Biasini, C; Chirico, G; Faden, D; Frassi, M; Lojacono, A; Marchesi, A; Motta, M; Tincani, A; Zatti, S; Zinzini, E, 2005)
"HCQ exposure and preeclampsia, along with other clinical data, were extracted from chart review."5.56Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies? ( Do, SC; Druzin, ML; Rizk, NM; Simard, JF, 2020)
" The HCQ group showed a trend towards lower dosage of prednisone (OR 0."5.46Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. ( de Hair, MJH; Derksen, RHWM; Fritsch-Stork, RDE; Kroese, SJ; Lely, AT; Limper, M; van Laar, JM, 2017)
"Hydroxychloroquine (HCQ) is the primary medication in the treatment of pregnancy with systemic lupus erythematosus (SLE) for its efficacy and safety."5.12Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis. ( Liu, Y; Wei, Y; Yang, H; Zhang, Y, 2021)
"Hydroxychloroquine (HCQ) is often needed to manage disease activity in systemic lupus erythematosus (SLE) during pregnancy."5.12Hydroxychloroquine in lupus pregnancy. ( Clowse, ME; Magder, L; Petri, M; Witter, F, 2006)
" Hydroxychloroquine (HCQ) appears protective against flares in pregnancy, neonatal congenital heart block and preterm birth."5.01Systemic lupus erythematosus in pregnancy: high risk, high reward. ( Do, SC; Druzin, ML, 2019)
"The objective of this meta-analysis was to determine whether gestational use of hydroxychloroquine (HCQ) for autoimmune disorders leads to an increase in the risk for adverse pregnancy outcomes."4.93Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. ( Kaplan, YC; Koren, G; Nickel, C; Ozsarfati, J, 2016)
"Findings from previous small studies have been reassuring regarding the safety of treatment with hydroxychloroquine (HCQ) during pregnancy."4.12Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study. ( Adam, MP; Braddock, SR; Burke, L; Chambers, CD; Felix, R; Fine, M; Johnson, DL; Jones, KL; Lessard, C; Luo, Y; Robinson, LK; Xu, R, 2022)
"Evaluate the impact of pregnancy physiology and medication non-adherence on serum hydroxychloroquine (HCQ) pharmacokinetics (PK) and exposure-response in SLE."4.12Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes. ( Balevic, SJ; Clowse, MEB; Cohen-Wolkowiez, M; Eudy, AM; Gonzalez, D; Hornik, CP; Maharaj, AR; Weiner, D, 2022)
"Among pregnancies exposed to 4-aminoquinolines (chloroquine and HCQ), no increased risk of major birth defects, preterm birth, or SGA was identified."4.02Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. ( Andersen, JT; Andersson, NW; Skov, L, 2021)
" Several management options for prolongation of pregnancy such as plasma exchange, pravastatin, LMHW, hydroxychloroquine/HCQ, or TNF-alpha blocker should be discussed with the patients."3.96Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases. ( Cervar-Zivkovic, M; Mayer-Pickel, K; Moertl, M; Schöll, W; Stern, C, 2020)
" Multiple logistic analysis adjusting for body mass index (BMI), lupus nephritis, serum uric acid, and estimated glomerular filtration rate revealed HCQ treatment was associated with exceedingly lower risk of preeclampsia in SLE pregnancy (odds ratio (OR) 0."3.91Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia. ( Cha, HS; Chae, J; Choi, SJ; Kim, YM; Oh, S; Roh, CR; Seo, MR, 2019)
" Lupus flares were predicted by HCQ discontinuation, a history of lupus nephritis, high pre-pregnancy serum uric acid and low C4 levels."3.81Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. ( Ju, JH; Ko, HS; Koh, JH; Kwok, SK; Park, SH, 2015)
"A total of 40 infants born from mothers affected by rheumatic diseases and treated with hydroxychloroquine during pregnancy were enrolled in a prospective observational study."3.73Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. ( Biasini, C; Chirico, G; Faden, D; Frassi, M; Lojacono, A; Marchesi, A; Motta, M; Tincani, A; Zatti, S; Zinzini, E, 2005)
"Pregnancy was formerly discouraged in patients with SLE because of unstable disease activity during the gestation period, increased thrombosis risk, severe organ damage, and inevitable side effects of immunosuppressive agents."2.82Pregnancy-related complications in systemic lupus erythematosus. ( Cui, L; Li, Z; Liu, Q; Mu, R; Qiao, J; Tan, Y; Yang, S, 2022)
"In the 1980's, pregnancies in systemic sclerosis (SSc) patients were considered to be at high risk for poor foetal and maternal outcome."2.44[Pregnancy in systemic sclerosis]. ( Bérezné, A; Mouthon, L, 2008)
"HCQ exposure and preeclampsia, along with other clinical data, were extracted from chart review."1.56Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies? ( Do, SC; Druzin, ML; Rizk, NM; Simard, JF, 2020)
"A history of lupus nephritis was noted in 29/121 (24%) patients."1.56Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists. ( Bhat, V; Haridas, V; Janardana, R; Jois, R; Pinto, B; Priya, V; Rao, VK; Shobha, V; Singh, Y; Srikantiah, C, 2020)
"Hydroxychloroquine was used to treat both patients; the first patient was treated with it over a period of 14 days before showing signs of improvement."1.56Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report. ( Atef-Yekta, R; Jafary, M; Lamsehchi, A; Sadeghi, K; Sagheb, S, 2020)
"Preterm birth was defined as a birth <37 weeks gestation."1.48Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus. ( Clowse, MEB; Eudy, AM; Haroun, T; James, AH; Jayasundara, M; Neil, L, 2018)
" The HCQ group showed a trend towards lower dosage of prednisone (OR 0."1.46Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. ( de Hair, MJH; Derksen, RHWM; Fritsch-Stork, RDE; Kroese, SJ; Lely, AT; Limper, M; van Laar, JM, 2017)

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (12.12)29.6817
2010's12 (36.36)24.3611
2020's17 (51.52)2.80

Authors

AuthorsStudies
Chambers, CD1
Johnson, DL1
Xu, R1
Luo, Y1
Felix, R1
Fine, M1
Lessard, C1
Adam, MP1
Braddock, SR1
Robinson, LK1
Burke, L1
Jones, KL1
Balevic, SJ1
Weiner, D1
Clowse, MEB2
Eudy, AM2
Maharaj, AR1
Hornik, CP1
Cohen-Wolkowiez, M1
Gonzalez, D1
Reynolds, JA1
Gayed, M1
Khamashta, MA1
Leone, F1
Toescu, V1
Bruce, IN1
Giles, I1
Teh, LS1
McHugh, N1
Akil, M1
Edwards, CJ1
Gordon, C1
Tan, Y1
Yang, S1
Liu, Q1
Li, Z1
Mu, R1
Qiao, J1
Cui, L1
Liu, Y2
Wei, Y2
Zhang, Y2
Yang, H2
Petri, M3
Do, SC2
Rizk, NM1
Druzin, ML3
Simard, JF1
Mayer-Pickel, K1
Stern, C1
Cervar-Zivkovic, M1
Schöll, W1
Moertl, M1
Janardana, R1
Haridas, V1
Priya, V1
Bhat, V1
Singh, Y1
Rao, VK1
Jois, R1
Srikantiah, C1
Pinto, B1
Shobha, V1
Sagheb, S1
Lamsehchi, A1
Jafary, M1
Atef-Yekta, R1
Sadeghi, K1
Di Mascio, D1
D'Antonio, F1
Beksac, MS1
Donmez, HG1
Hammad, I1
Porter, TF1
Andersson, NW1
Skov, L1
Andersen, JT1
Ortiz Molina, E1
Hernandez Pailos, R1
Pola Guillen, M1
Pascual Pedreno, A1
Rodriguez Rodriguez, E1
Hernandez Martinez, A1
Dubey, P1
Thakur, B1
Reddy, S1
Martinez, CA1
Nurunnabi, M1
Manuel, SL1
Chheda, S1
Bracamontes, C1
Dwivedi, AK1
Lateef, A1
Jayasundara, M1
Haroun, T1
Neil, L1
James, AH1
Kroese, SJ1
de Hair, MJH1
Limper, M1
Lely, AT1
van Laar, JM1
Derksen, RHWM1
Fritsch-Stork, RDE1
Guillotin, V1
Bouhet, A1
Barnetche, T1
Richez, C1
Truchetet, ME1
Seneschal, J1
Duffau, P1
Lazaro, E2
Chehab, G1
Krüssel, J1
Fehm, T1
Fischer-Betz, R1
Schneider, M1
Germeyer, A1
Suerdieck, MB1
Kreuzer, V1
Liebenthron, J1
Seo, MR1
Chae, J1
Kim, YM1
Cha, HS1
Choi, SJ1
Oh, S1
Roh, CR1
Koh, JH1
Ko, HS1
Kwok, SK1
Ju, JH1
Park, SH1
Leroux, M1
Desveaux, C1
Parcevaux, M1
Julliac, B1
Gouyon, JB1
Dallay, D1
Pellegrin, JL1
Boukerrou, M1
Blanco, P1
Kaplan, YC1
Ozsarfati, J1
Nickel, C1
Koren, G1
Schreiber, K1
Hunt, BJ1
Bérezné, A1
Mouthon, L1
Iba-Ba, J1
Mayi-Tsonga, S1
Ibouili Bignoumba, R1
Diallo, T1
Moussavou Kombila, JB1
Coniquet, S1
Mihindou Boussougou, C1
Boguikouma, JB1
Langen, ES1
Chakravarty, EF1
Liaquat, M1
El-Sayed, YY1
Motta, M1
Tincani, A1
Faden, D1
Zinzini, E1
Lojacono, A1
Marchesi, A1
Frassi, M1
Biasini, C1
Zatti, S1
Chirico, G1
Clowse, ME1
Magder, L1
Witter, F1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174]420 participants (Anticipated)Interventional2019-08-02Recruiting
Hydroxychloroquine Exposure in Systemic Lupus Erythematosus (SLE)[NCT03802188]3,700 participants (Anticipated)Observational2018-05-09Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for hydroxychloroquine and Premature Birth

ArticleYear
Pregnancy-related complications in systemic lupus erythematosus.
    Journal of autoimmunity, 2022, Volume: 132

    Topics: Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Systemic; Pregnancy; Pregn

2022
Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis.
    Clinical rheumatology, 2023, Volume: 42, Issue:5

    Topics: Autoimmune Diseases; Case-Control Studies; Female; Humans; Hydroxychloroquine; Hypertension, Pregnan

2023
Pregnancy and Systemic Lupus Erythematosus.
    Best practice & research. Clinical obstetrics & gynaecology, 2020, Volume: 64

    Topics: Adult; Antimalarials; Antiphospholipid Syndrome; Female; Humans; Hydroxychloroquine; Infant, Newborn

2020
Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis.
    Archives of gynecology and obstetrics, 2021, Volume: 303, Issue:2

    Topics: Adult; Antirheumatic Agents; Female; Gestational Age; Humans; Hydroxychloroquine; Lupus Erythematosu

2021
An Update on Biologic Agents During Pregnancy.
    Clinics in perinatology, 2020, Volume: 47, Issue:4

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humani

2020
Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.
    BMC pregnancy and childbirth, 2021, Mar-24, Volume: 21, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Asia; Cesarean Section; COVID-19; COVID-19 Drug Trea

2021
Systemic Lupus Erythematosus and Pregnancy.
    Rheumatic diseases clinics of North America, 2017, Volume: 43, Issue:2

    Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Female; Fetal Growth Retardation; Humans; Hydroxychlo

2017
Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.
    Joint bone spine, 2018, Volume: 85, Issue:6

    Topics: Antirheumatic Agents; Female; Fetal Growth Retardation; Humans; Hydroxychloroquine; Infant, Newborn;

2018
Systemic lupus erythematosus in pregnancy: high risk, high reward.
    Current opinion in obstetrics & gynecology, 2019, Volume: 31, Issue:2

    Topics: Adult; Counseling; Female; Fetal Growth Retardation; Humans; Hydroxychloroquine; Lupus Erythematosus

2019
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.
    British journal of clinical pharmacology, 2016, Volume: 81, Issue:5

    Topics: Abortion, Spontaneous; Antirheumatic Agents; Autoimmune Diseases; Female; Humans; Hydroxychloroquine

2016
Pregnancy and Antiphospholipid Syndrome.
    Seminars in thrombosis and hemostasis, 2016, Volume: 42, Issue:7

    Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Female; Fetal Growth Retardation; Humans; H

2016
[Pregnancy in systemic sclerosis].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antirheumatic Agents; Female; Fetal Diseases; Humans; Hydr

2008

Trials

1 trial available for hydroxychloroquine and Premature Birth

ArticleYear
Hydroxychloroquine in lupus pregnancy.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:11

    Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu

2006
Hydroxychloroquine in lupus pregnancy.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:11

    Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu

2006
Hydroxychloroquine in lupus pregnancy.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:11

    Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu

2006
Hydroxychloroquine in lupus pregnancy.
    Arthritis and rheumatism, 2006, Volume: 54, Issue:11

    Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu

2006

Other Studies

20 other studies available for hydroxychloroquine and Premature Birth

ArticleYear
Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study.
    Arthritis & rheumatology (Hoboken, N.J.), 2022, Volume: 74, Issue:4

    Topics: Abortion, Spontaneous; Cohort Studies; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn;

2022
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes.
    Lupus science & medicine, 2022, Volume: 9, Issue:1

    Topics: Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Syst

2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine.
    Rheumatology (Oxford, England), 2023, 03-01, Volume: 62, Issue:3

    Topics: Adolescent; Antirheumatic Agents; Azathioprine; Child; Female; Humans; Hydroxychloroquine; Lupus Ery

2023
Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies?
    American journal of perinatology, 2020, Volume: 37, Issue:9

    Topics: Adult; Antirheumatic Agents; California; Female; Humans; Hydroxychloroquine; Logistic Models; Lupus

2020
Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases.
    Journal of reproductive immunology, 2020, Volume: 138

    Topics: Adult; Antiphospholipid Syndrome; Female; Fetal Viability; Gestational Age; Heparin, Low-Molecular-W

2020
Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists.
    Lupus, 2020, Volume: 29, Issue:11

    Topics: Abortion, Spontaneous; Adult; Female; Humans; Hydroxychloroquine; India; Infant, Newborn; Lupus Eryt

2020
Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report.
    Italian journal of pediatrics, 2020, Sep-21, Volume: 46, Issue:1

    Topics: Adult; Antiviral Agents; Betacoronavirus; Blood Chemical Analysis; Coronavirus Infections; COVID-19;

2020
Perinatal mortality and morbidity of SARS-COV-2 infection during pregnancy in European countries: Findings from an international study.
    European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 256

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Asia; Asymptomatic Infections; Austr

2021
Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug.
    The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:2

    Topics: Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Immune System; Infant, Newborn; Pharmaceut

2021
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study.
    Rheumatology (Oxford, England), 2021, 05-14, Volume: 60, Issue:5

    Topics: Adolescent; Adult; Antimalarials; Chloroquine; Cohort Studies; Denmark; Female; Humans; Hydroxychlor

2021
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
    Ginekologia polska, 2020, Volume: 91, Issue:12

    Topics: Adult; Anosmia; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; C-Reactive Protein; Cesarea

2020
Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus.
    Lupus, 2018, Volume: 27, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cesarean Section; Female; Ges

2018
Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births.
    Journal of immunology research, 2017, Volume: 2017

    Topics: Adult; Antibodies, Antiphospholipid; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Infan

2017
Successful conception in a 34-year-old lupus patient following spontaneous pregnancy after autotransplantation of cryopreserved ovarian tissue.
    Lupus, 2019, Volume: 28, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cryopreservation; Cyclophosphamide; Female;

2019
Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
    Lupus, 2019, Volume: 28, Issue:6

    Topics: Adult; Antirheumatic Agents; Female; Gestational Age; Humans; Hydroxychloroquine; Infant, Newborn; L

2019
Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.
    Lupus, 2015, Volume: 24, Issue:2

    Topics: Adult; Antirheumatic Agents; Apgar Score; Female; Fetal Growth Retardation; Follow-Up Studies; Human

2015
Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.
    Lupus, 2015, Volume: 24, Issue:13

    Topics: Adult; Antirheumatic Agents; Cohort Studies; Female; Fetal Growth Retardation; Gestational Age; Gluc

2015
[Dermatomyositis and pregnancy: a case in Gabon].
    Medecine tropicale : revue du Corps de sante colonial, 2009, Volume: 69, Issue:5

    Topics: Adult; Antirheumatic Agents; Cesarean Section; Dermatomyositis; Female; Gabon; Glucocorticoids; Huma

2009
High rate of preterm birth in pregnancies complicated by rheumatoid arthritis.
    American journal of perinatology, 2014, Volume: 31, Issue:1

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Congenital Abnormalities; Female; Fetal Distress

2014
Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation.
    Journal of perinatology : official journal of the California Perinatal Association, 2005, Volume: 25, Issue:2

    Topics: Antirheumatic Agents; Breast Feeding; Child Development; Female; Follow-Up Studies; Humans; Hydroxyc

2005